Related Experiment Video
Updated: Aug 7, 2026

Induction of an Inflammatory Response in Primary Hepatocyte Cultures from Mice
Published on: March 10, 2017
Hepatocyte growth factor: Effects on immune-mediated heart diseases
Mitsuaki Isobe1, Hideki Futamatsu, Jun-ichi Suzuki
1Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Bunkyoku, Tokyo, Japan. isobemi.cvm@tmd.ac.jp
Insights
Hepatocyte growth factor (HGF) shows promise for treating cardiovascular diseases, including autoimmune heart conditions. HGF effectively suppresses immune responses involved in cardiac allograft rejection and myocarditis.
Area of Science:
- Cardiovascular Science
- Immunology
- Regenerative Medicine
Background:
- Growing evidence suggests hepatocyte growth factor (HGF) plays a significant role in cardiovascular health.
- HGF demonstrates beneficial effects in conditions like myocardial infarction, heart failure, and peripheral arterial disease.
Purpose of the Study:
- To review recent advancements in the therapeutic applications of HGF for various heart diseases.
- To focus on the utility of HGF in managing immune-mediated heart conditions.
- To explore the mechanisms by which HGF suppresses T-cell-mediated immunity.
Main Methods:
- Literature review of recent studies on HGF in cardiovascular diseases.
- Analysis of HGF's role in both non-immune and immune-mediated cardiac pathologies.
- Discussion of proposed mechanisms for HGF's immunomodulatory effects.
Main Results:
- HGF administration is effective in suppressing acute and chronic cardiac allograft rejection.
- HGF shows efficacy in treating autoimmune myocarditis.
- HGF exhibits protective effects in myocardial infarction, heart failure, and occlusive peripheral arterial disease.
Conclusions:
- HGF holds significant therapeutic potential for a range of cardiovascular diseases, particularly immune-mediated conditions.
- Further research into HGF's immunomodulatory mechanisms could lead to novel treatment strategies for heart diseases.
Abstract:
There is growing evidence of the potential role of hepatocyte growth factor (HGF) in various cardiovascular diseases. In addition to the beneficial effects of HGF in myocardial infarction, heart failure, and occlusive peripheral arterial disease, administration of HGF effectively suppresses acute and chronic cardiac allograft rejection and autoimmune myocarditis. The present review summarizes recent advances in the utility of HGF for heart diseases, especially immune-mediated heart diseases. Possible mechanisms of action in the suppression of T-cell-mediated immunity are also discussed.
Related Concept Videos
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Cirrhosis II: Pathophysiology
Rheumatic Heart Disease I: Introduction
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Myocarditis I: Introduction
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
